Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (2)
  • 2024 (2)
  • 2023 (5)
  • 2022 (8)
  • 2021 (9)

Subject

  • Drug Trafficking (1778)
  • Synthetic drugs (677)
  • Fake Pills (542)
  • Guns/Weapons (483)
  • OCDETF/Task Force (401)
  • Seizures (Drugs/Property) (253)
  • Arrests/Convictions - Major (246)
  • Overdose (220)
  • Guilty Plea (168)
  • Major Law Enforcement Operation (125)
  • Task Forces/Task Force Officers (111)
  • Fentanyl Awareness (82)
  • One Pill Can Kill (68)
  • Gangs (61)
  • Prescription Drugs (56)
  • Outreach/Drug Prevention (55)
  • Money Laundering (54)
  • HIDTA (53)
  • Press Conferences (39)
  • Diversion Division (32)
  • Narcoterrorism (23)
  • Counterfeit Pills (22)
  • Prevention/Education - DEA websites GSAD, JTT etc (19)
  • Extraditions (12)
  • Fentanyl Free America (12)
  • Public and Media Affairs - also see Congressional Affairs (11)
  • Asset Forfeiture (10)
  • Dark Web- Internet Trafficking (10)
  • International/Foreign Operations (4)
  • Campaigns (3)
  • Intelligence Division - Intelligence Products (2)
  • Terrorism (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • El Paso Intelligence Center (1)
  • Intergovernmental Affairs (1)
  • Other (1)
  • Take Back Day (1)
  • Pharmaceuticals/Pharmacists/Physicians (28)

Drug Name

  • Oxycodone (48)
  • Opioids (45)
  • Hydromorphone (15)
  • Synthetic Opioids (12)
  • Morphine (8)
  • Benzodiazepines (7)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • Cocaine (2)
  • GHB (1)
  • Heroin (1)
  • Fentanyl (28)

Field Division

  • St. Louis (8)
  • Washington, DC (7)
  • Chicago (3)
  • Seattle (3)
  • New York (2)
  • Atlanta (1)
  • Dallas (1)
  • El Paso (1)
  • Houston (1)
  • New England (1)
Clear All Results
28 Results - Showing 11 to 20
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
PRESS RELEASE

Nurse at St. Louis County Hospital Admits Fraudulently Obtaining Fentanyl

ST. LOUIS – A nurse at a St. Louis County, Missouri, hospital pleaded guilty to a federal felony Thursday and admitted fraudulently obtaining fentanyl for her own personal use. Lindsay J. Maupin, 31, of Cape Girardeau, pleaded guilty in front of U.S. District Judge Stephen R. Clark to one felony...
PRESS RELEASE

Physician Sentenced after Taking Bribes from Drug Manufacturer

SPRINGFIELD, Mo. – A Nixa, Mo., physician was sentenced in federal court today after taking bribes from a drug manufacturer in exchange for prescribing its fentanyl drug to his patients so often that he ranked highest in the state in net sales of the product. Randall Halley, 65, was sentenced...
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
PRESS RELEASE

Illinois Dentist Charged with Tampering with Drugs Administered to Patients and Other Crimes

SPRINGFIELD, Ill. – Robert Bell, Special Agent in Charge of the Drug Enforcement Administration-Chicago Division, and U.S. Attorney Gregory K. Harris of the Central District of Illinois announced that a federal grand jury returned an indictment against Phillip Jensen, DMD, 61, of Rochester, Illinois, on Feb. 1, 2022, charging him...
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
PRESS RELEASE

Thirteen Arrested for Fentanyl Distribution

AUSTIN – Today 13 individuals were arrested on criminal charges for their alleged involvement in fentanyl distribution announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux and United States Attorney Ashley C. Hoff. According to court documents, Marcos Garcia, 18, of Somerton, AZ; Oliver Garcia, 20, of...
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Current page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster